Andersen, Asger http://orcid.org/0000-0002-9102-3130
Waziri, Farhad
Schultz, Jacob Gammelgaard
Holmboe, Sarah
Becker, Søren Warberg
Jensen, Tage
Søndergaard, Hanne Maare
Dodt, Karen Kaae
May, Ole
Mortensen, Ulrik Markus
Kim, Won Yong
Mellemkjær, Søren
Nielsen-Kudsk, Jens Erik
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
https://doi.org/10.1186/s12890-021-01440-7
Funding for this research was provided by:
Novo Nordisk Fonden (NNF16OC0023244)
Article History
Received: 3 March 2020
Accepted: 19 February 2021
First Online: 28 February 2021
Ethics approval and consent to participate
: The study protocol was approved by the Danish Ethics Committee in the Central Region of Denmark (File# 44099) and study data management by the Danish Data Protection Agency in the Central Region of Denmark (File# 1-16-02-574-14). All patients gave informed written consent before inclusion. The study was retrospectively registered February 2nd 2020 at ExternalRef removed (NCT04283240).
: Not applicable.
: AA have received travel grants and lecturing fees from MSD, Medtronic, Abbot, Astra Zenica, Boehringer Ingelheim. JS has received lecturing fees from MSD. SB have received travel grants from Pfizer/BMS and Boehringer Ingelheim. HMS have received travel grants and lecturing fees from Astra Zeneca. SM, WYK, OM, SH, KKD, FW, JENK, TJ, UMM report no competing interests.